High immunohistochemical expression of NRP2 in patients with HNSCC has been observed to increase lymphatic vascular density and lymphovascular invasion, with a higher risk of regional involvement and decreased survival [12,13]. Here, NRP2 is linked to head and neck squamous cell carcinoma.